Literature DB >> 18021511

The use of databases for quality assessment in rheumatoid arthritis.

T A Stamm1, D Aletaha, S Pflugbeil, T Kapral, K Montag, K P Machold, J S Smolen.   

Abstract

As resources in health care systems become increasingly scarce, rheumatologists may need to provide evidence that their quality of care uses the allocated resources effectively by achieving a good outcome for patients with rheumatoid arthritis (RA). In order to assess quality, it has been recommended in other areas of medicine to gather data according to appropriate outcome measures, preferably in electronic databases, enabling identification of benchmarks to compare the outcome quality of different clinical settings. Available electronic applications commonly comprise a database for data processing and storage, as well as a tool for regularly measuring and following disease activity in individual patients. Access to aggregated data makes it possible to monitor disease activity in individual patients over time in relation to treatment. In addition, electronic applications should allow the extraction of patient data according to special characteristics for analysis. In this way, such electronic applications can provide a central database that can be used for monitoring patients in routine care, case studies or general research, as well as facilitating comparisons of quality of care in different centres or in different countries for reference purposes.

Entities:  

Mesh:

Year:  2007        PMID: 18021511

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

Review 1.  Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review.

Authors:  Lilian H D van Tuyl; David T Felson; George Wells; Josef Smolen; Bin Zhang; Maarten Boers
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-01-15       Impact factor: 4.794

2.  Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy.

Authors:  Alessandra Della Rossa; Rossella Neri; Rosaria Talarico; Marica Doveri; Arianna Consensi; Stefano Salvadori; Valentina Lorenzoni; Giuseppe Turchetti; Stefania Bellelli; Massimiliano Cazzato; Laura Bazzichi; Paolo Monicelli; Stefano Moscardini; Stefano Bombardieri
Journal:  Clin Rheumatol       Date:  2009-10-06       Impact factor: 2.980

3.  Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs.

Authors:  Helga Radner; Josef S Smolen; Daniel Aletaha
Journal:  Arthritis Res Ther       Date:  2014-02-21       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.